Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services has informed stock exchanges that it has received two Stay Orders against a previously reported suspension from authorities in Bhandara, Maharashtra. This is an update to its earlier submission dated 13 February 2025. The Stay Orders effectively pause or overturn the earlier suspension action against the company in that jurisdiction. The full details have been posted on the company's website and on the BSE/NSE portals.
Positive short-term relief for shareholders as the regulatory action against the company in Bhandara has been stayed, reducing immediate operational risk in that region. However, the matter remains under adjudication, so the final outcome is still pending.